Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

other Versions

You are currently viewing an earlier version of this article (June 30, 2024).
View the most recent version of this article

Original research

Real-world use of immune checkpoint inhibitors in advanced or recurrent endometrial cancer

Online download statistics by month:

Online download statistics by month: June 2024 to December 2024

	Abstract	Full	Pdf
Jun 2024	63	1	0
Jul 2024	2207	52	32
Aug 2024	216	13	15
Sep 2024	175	9	7
Oct 2024	142	8	6
Nov 2024	463	411	133
Dec 2024	29	27	6
Total	3295	521	199